EXTR STOCK ALERT: Extreme Networks, Inc. Investors are Notified of Imminent October 15 Deadline in Class Action; Inform BFA Law if you...

DXCM STOCK ALERT: DexCom, Inc. Investors are Notified of Imminent October 21 Deadline in Class Action; Inform BFA Law if you Incurred Losses...

FIVE STOCK ALERT: Five Below, Inc. Investors are Notified of Imminent September 30 Deadline in Class Action; Inform BFA Law if you Incurred...

MXL STOCK ALERT: MaxLinear, Inc. Investors are Informed of Ongoing Securities Fraud Investigation; Inform BFA Law if you Incurred Losses ...

BEN STOCK ALERT: Franklin Resources, Inc. Investors are Informed of Ongoing Securities Fraud Investigation; Inform BFA Law if you Incurred...

FORD STOCK ALERT: Ford Motor Company Investors are Notified of Imminent October 7 Deadline in Class Action; Inform BFA Law if you Incurred...

ABR STOCK ALERT: Arbor Realty Trust, Inc. Investors are Notified of Imminent September 30 Deadline in Class Action; Inform BFA Law if you...

SMCI STOCK ALERT: Super Micro Computer, Inc. Investors are Notified of Imminent October 29 Deadline in Class Action; Inform BFA Law if you...

Precede Biosciences Presents New Data at ESMO 2024 Demonstrating Ability to Reveal Tumor PSMA Expression from a Simple Blood Test that is...

ESMO 2024 - ImmVira Unveils Clinical Results of Intravesical MVR-T3011 for High-Risk BCG-Failure NMIBC Patients

OC Smile Experts Redefines Luxury Beauty with Personalized Dental Aesthetics

OC Smile Experts Redefines Luxury Beauty with Personalized Dental Aesthetics

Hispanic Heritage month: The Children's Museum of Indianapolis Unveils Take Me There®: Peru and Launches Latino Community Initiative to...

Monster Energy's Kokomo Murase Claims First Place in Women's Snowboard Slopestyle at Winter Games NZ FIS Snowboard Slopestyle World Cup in...

Sepsis Awareness Reaches 69%, While Misconceptions About Sepsis and Infections Exist

Akeso Published First-Ever Efficacy Data for PD-1/VEGF Bispecific Antibody Ivonescimab with or without CD47 Antibody plus FOLFOXIRI for mCRC...

Akeso Published Ivonescimab plus Ligufalimab as First-Line Treatment for PD-L1-Positive Recurrent/Metastatic Head and Neck Squamous Cell...

Mango Animate Developed a Free AI Video Generator for Creators

23andMe Therapeutics Announces Positive In Vivo Results for 23ME-01473, a Dual-Mechanism ULBP6-Targeting Antibody Currently in a Phase 1...

Healing Through Words: From Rupi Kaur to Amanda Lovelace, Meet the Poets Leading the Way, and Announcing Beth E. Aubut's Powerful New Poetry...